HeartBeam Secures Two New U.S. Patents for Revolutionary 3D ECG Technology

HeartBeam announced the issuance of two new U.S. patents that strengthen its intellectual property portfolio and support the company's expansion in remote cardiac diagnostics. The new patents protect core technologies behind HeartBeam's compact, cable-free 3D ECG device and its rhythm analysis algorithm capable of identifying arrhythmias through continuous signal input. This development is significant as it addresses the growing need for accessible cardiac monitoring solutions that can provide accurate diagnostics outside traditional healthcare settings.

The 3D ECG device, which uses chest and finger electrodes to collect high-fidelity signals in three non-coplanar directions, is designed for on-demand symptom recording and 12-lead ECG synthesis. Its software is currently under FDA review, backed by data from the VALID-ECG pivotal study. The rhythm algorithm works across cardiac monitoring systems and triggers targeted data collection during abnormal rhythm detection, enhancing diagnostic precision. This technology represents a major advancement in portable cardiac care, potentially enabling earlier detection of heart conditions and reducing the need for hospital visits.

With 20 issued patents and 34 additional filings, HeartBeam continues to solidify its position at the forefront of digital cardiac care innovation. The company's future plans to incorporate AI capabilities for enhanced diagnostic accuracy could further revolutionize how cardiac health is monitored and managed. For more information about the company's technology, visit https://www.HeartBeam.com. The latest updates relating to BEAT are available at https://ibn.fm/BEAT.

The implications of these patent issuances extend beyond corporate intellectual property protection. They represent a significant step toward making sophisticated cardiac diagnostics more accessible to patients in remote or home settings. The technology's ability to capture 12-lead ECG data without cables could democratize cardiac care, particularly for patients in rural areas or those with limited mobility. As the population ages and the prevalence of cardiac conditions increases, such innovations in remote monitoring technology become increasingly critical for effective healthcare delivery and early intervention strategies.